BIOMAT Database Logo BIOMAT Database Logo

Long-term survival in acute leukemia. Twenty-two adult patients surviving for over five years. 1986

S A Evensen, and P Stavem

An intermittent combination chemotherapy program was initiated in 1971-79 in 172 patients, aged 15-59 years, with acute leukemia (131 myelogenous (AML) and 41 lymphoblastic (ALL]. Sixteen patients with AML and 6 with ALL have survived for more than 5 years. These long-term survivors represent 24% of AML and 18% of ALL patients who obtained complete remission. Twelve patients (10 AML and 2 ALL) are in continuous first remission 5.5-13.5 years after diagnosis. Occasional late relapses up to 9 years after diagnosis make it impossible to declare any individual patient cured.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

S A Evensen, and P Stavem
[Favorable prognoses in 24 adult patients with acute leukemia, surviving over five years since 1985].
July 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S A Evensen, and P Stavem
[Two cases of acute myelogenous leukemia of adult surviving more than five years (author's transl)].
February 1972, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S A Evensen, and P Stavem
[Long-term survival of adult patients with acute leukemia].
January 1983, Acta haematologica Polonica,
S A Evensen, and P Stavem
[Study of acute leukemia patients surviving over 5 years in Japan].
November 1971, Saishin igaku. Modern medicine,
S A Evensen, and P Stavem
Long-term relapse-free survival in adult acute lymphoblastic leukemia.
February 1985, Cancer treatment reports,
S A Evensen, and P Stavem
Long-term survival in adolescent and adult acute lymphoblastic leukemia.
July 1983, Cancer,
S A Evensen, and P Stavem
Long-term survival in adult acute leukemia. A multicenter study of 56 patients.
June 1982, Haematologica,
S A Evensen, and P Stavem
[Long-term Outcome over Five Years after Surgical Revascularization in Adult Moyamoya Disease].
October 2016, No shinkei geka. Neurological surgery,
S A Evensen, and P Stavem
Long-term results of spinal instrumentation surgery for scoliosis five years or more after surgery, in patients over twenty-three years of age.
July 1989, Spine,
S A Evensen, and P Stavem
Acute leukemia long-term survival.
March 1972, Cancer,
Copied contents to your clipboard!